<DOC>
	<DOCNO>NCT02136316</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability well pharmacokinetics increase oral multiple dos ASP7962 healthy young male female subject .</brief_summary>
	<brief_title>A Study Assess Safety , Tolerability Pharmacokinetics ( PK ) Multiple Ascending Doses ASP7962 Healthy Subjects</brief_title>
	<detailed_description>Subjects admit clinical unit stay residential total 20 days/19 night , discharge clinical unit day 19 .</detailed_description>
	<criteria>Subject body mass index 18.5 30.0 kg/m2 , inclusive . Subject weigh least 50 kg . Female subject must nonchildbearing potential : Postmenopausal ( define least 1 year without menses confirmation FSH level ) prior screen , Documented surgically sterile status posthysterectomy ( least 1 month prior screen ) . Male subject female spouse/partner childbearing potential must use 2 highly effective form birth control ( 1 must barrier method ) start screen continue throughout clinical study period , 90 day final study drug administration . Male subject must donate sperm start screening , throughout clinical study period , 90 day final study drug administration . Subject agree participate another interventional study participate present clinical study , define signing informed consent form completion last study visit . Subject know suspected hypersensitivity ASP7962 component formulation use . Subject history suicide attempt suicidal behavior . Any suicidal ideation within last 3 month . Subject liver function test ( aspartate aminotransferase [ AST ] , alanine aminotransferase [ ALT ] , alkaline phosphatase , gamma glutamyl transferase , total bilirubin [ TBL ] ) upper limit normal [ ULN ] . In case assessment may repeat [ day 1 ] . Subject clinically significant history allergic condition . Subject has/had febrile illness symptomatic , viral , bacterial ( include upper respiratory infection ) , fungal ( noncutaneous ) infection within 1 week prior admission clinical unit day 1 . Subject mean pulse rate &lt; 40 &gt; 90 bpm ; mean systolic blood pressure ( SBP ) &gt; 140 mmHg ; mean diastolic blood pressure ( DPB ) &gt; 90 mmHg ( vital sign measurement take triplicate subject rest supine position 5 minute ; pulse rate measure automatically ) [ day 1 ] . If mean pulse rate , mean SBP mean DBP range specify , 1 additional triplicate measurement may take day 1 . Subject mean correct QT interval use Fridericia 's formula ( QTcF ) interval &gt; 430 m ( male subject ) &gt; 450 m ( female subject ) admission clinical unit day 1 . If mean QTcF exceed limit , 1 additional triplicate ECG take [ day 1 ] . Subject use prescribe nonprescribed drug ( include vitamin , natural herbal remedy , e.g. , St. John 's wort ) 2 week prior study drug administration , except occasional use paracetamol ( 2 g/day ) . Subject use nicotinecontaining product within 6 month prior admission clinical unit . Subject history drink 21 unit alcohol per week male subject 14 unit alcohol per week female subject ( 1 unit = 10 g pure alcohol = 250 mL beer [ 5 % ] 35 mL spirit [ 35 % ] 100 mL wine [ 12 % ] ) within 3 month prior admission clinical unit . Subject use drug abuse within 3 month prior admission clinical unit . Subject use inducer metabolism ( e.g. , barbiturate , rifampin ) 3 month prior admission clinical unit . Subject significant blood loss , donate 1 unit ( 500 mL ) blood , receive transfusion blood blood product within 60 day donate plasma within 7 day prior admission clinical unit . Subject positive serology test hepatitis B surface antigen , hepatitis A virus antibody ( immunoglobulin M ) , hepatitis C virus antibody , antibody human immunodeficiency virus type 1 ( HIV1 ) and/or type 2 ( HIV2 ) screening . Subject participate clinical study treat investigational drug within 28 day 5 halflives , whichever longer , prior screen . Subject employee Astellas Group Contract Research Organization involve clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>ASP7962</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>